SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-97-002958
Filing Date
1997-03-26
Accepted
1997-03-26 00:00:00
Documents
15
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 PHARMACEUTICAL PRODUCT DEVELOPMENT INC 12/31/96 10-K 279744
2 AMENDED AND RESTATED BYLAWS EX-3.2 73183
3 EMPLOYMENT AGREEMENT 9/26/96 PPD/DAVENPORT EX-10.81 14158
4 EMPLOYMENT AGREEMENT 9/25/96 PPD/BAKER EX-10.82 10634
5 SUBSTITUTE NON-STATUTORY STOCK OPTION AGREEMENTS EX-10.83A 7163
6 SUBSTITUTE NON-STATUTORY STOCK OPTION AGREEMENTS EX-10.83B 7169
7 SUBSTITUTE NON-STATUTORY STOCK OPTION AGREEMENTS EX-10.83C 7170
8 SUBSTITUTE NON-STATUTORY STOCK OPTION AGREEMENTS EX-10.83D 7162
9 SUBSTITUTE NON-STATUTORY STOCK OPTION AGREEMENTS EX-10.83E 7166
10 SUBSTITUTE NON-STATUTORY STOCK OPTION AGREEMENTS EX-10.83F 7420
11 SUBSIDIARIES OF THE REGISTRANT EX-21 5438
12 CONSENT OF COOPERS & LYBRAND LLP EX-23.1 651
13 CONSENT OF ARTHUR ANDERSEN LLP EX-23.2 501
14 FINANCIAL DATA SCHEDULE EX-27 2373
15 REPORT OF ARTHUR ANDERSEN LLP EX-99 2073
  Complete submission text file 0000950144-97-002958.txt   435051
Mailing Address
Business Address 3151 17TH STREET EXTENSION WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 97564119
SIC: 8731 Services-Commercial Physical & Biological Research